ESMO VIRTUAL CONGRESS 2020 - Selection of some sessions of interest

GO TO Presentation: 

Bayer - Precision medicine in Real-world clinical practice: Perspectives from a multidisciplinary team

GO TO Session: 

Bristol Myers Squibb - The future is now: Transforming management of GI cancer with immuno-oncology

GO TO Session: 

Pierre Fabre - BRAF V600E-mutant mCRC: Spotlight on the patient journey

GO TO Session: 

Servier - Can current treatment strategies for mCRC be further optimized?

GO TO Session: 

Servier - Joining efforts beyond first-line management in patients with metastatic pancreatic cancer

GO TO Session:

Eli Lilly and Company - Precision Medicine Implementation in the Clinic: RET as a potential target in cancer treatment

GO TO Session:

Eli Lilly and Company - Are single agent TKIs still Standard of Care in EGFR mutant Non-Small Cell Lung Cancer or should they be combined with other agents?

For more sessions: GO TO Website ESMO VIRTUAL CONGRESS 2020